New Recommendations for HIV Patients

The World Health Organisation urges countries to phase out the use of Stavudine because of its long-term, irreversible side-effects in HIV patients

The World Health Organisation (WHO) has urged countries to phase out the use of Stavudine, the most widespread anti-retroviral, because of what it calls long-term, irreversible side-effects in HIV patients,  including wasting and a nerve disorder.

In sweeping changes to its guidelines, the WHO also recommends that people with HIV, including pregnant women, should start taking antiretroviral drugs earlier to live a longer and healthier life.

For the first time WHO advises HIV-positive women and their babies to take the drugs while breastfeeding to prevent mother-to-child transmission of the virus that causes AIDS.

Dr. Siobhan Crowley of WHO’s HIV/AIDS department, says that, “The new recommendations are based on a solid body of evidence indicating that rates of death, morbidity and HIV and tuberculosis transmissions are all reduced by starting treatment earlier. This prolongs and improves quality of life.”

To read the article titled, “WHO issues new recommendations for HIV patients,” click here.

Source: 
Sowetan

NGO Services

NGO Services

NGO Events

S M T W T F S
 
 
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
 
26
 
27
 
28
 
29